XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:            
Net income $ 65,108 $ 61,757 $ 136,968 $ 185,265    
Adjustments to reconcile net income to net cash provided by operating activities:            
Stock-based compensation 5,930 6,148 18,169 18,298    
Depreciation and amortization     11,138 15,425    
Loss on disposal of fixed assets     204 312    
Impairment of lease right-of-use asset     95 0    
Deferred taxes     0 (2,364)    
Accrued interest on note receivable - related party     (6) (12)    
Notes receivable - related party     307 307    
Change in valuation of contingent payment liabilities     0 (6,520)    
Other operating activities     417 0    
Changes, net of acquisitions, in:            
Accounts receivable     (20,601) (25,623)    
Factor accounts receivable     93,274 (23,841)    
Inventories     23,541 6,842    
Prepaid expenses, income tax receivables, prepaid taxes, and other assets     (264) 120    
Accounts payable and accrued expenses     4,991 (140,144)    
Accrued incentive compensation     (1,598) (3,448)    
Leases and other liabilities     (2,331) (5,213)    
Payment of contingent consideration     0 (339)    
Net Cash Provided by (Used in) Operating Activities     77,756 66,747    
Cash flows from investing activities:            
Capital expenditures 6,106 4,852 13,899 10,115    
Purchase of a trademark     0 2,000 $ 2,000  
Purchases of short-term investments     15,979 38,951    
Maturity/sale of short-term investments     16,335 73,726    
Net cash (used in)/provided by investing activities     (13,543) 22,660    
Cash flows from financing activities:            
Common stock purchased for treasury     (104,215) (112,105)    
Proceeds from exercise of stock options 371 0 1,171 415    
Investment of noncontrolling interest     4,582 0    
Cash dividends paid on common stock     (47,594) (49,774)    
Payment of contingent consideration     0 (4,770)    
Distribution of noncontrolling interest 1,102   1,102 0    
Net cash used in financing activities     (147,158) (166,234)    
Effect of exchange rate changes on cash and cash equivalents     36 (3,478)    
Net decrease in cash and cash equivalents     (82,909) (80,305)    
Cash and cash equivalents $ 191,804 $ 139,194 $ 191,804 $ 139,194 $ 274,713 $ 219,499